Canada Markets closed

Revive Therapeutics Ltd. (RVV.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.4900+0.0300 (+6.52%)
At close: 3:59PM EDT
Full screen
Previous Close0.4600
Bid0.4850 x N/A
Ask0.4950 x N/A
Day's Range0.4550 - 0.4900
52 Week Range0.1750 - 0.9200
Avg. Volume573,370
Market Cap155.359M
Beta (5Y Monthly)0.15
PE Ratio (TTM)N/A
EPS (TTM)-0.0610
Earnings DateOct. 26, 2021 - Nov. 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Baystreet

    ETF Inclusion Sends Psychedelic Stock Soaring

    There are a few different events that can take place that naturally create buying pressure for a stock. ...

  • GlobeNewswire

    Revive Therapeutics Included in AdvisorShares® Newly Launched Psychedelics ETF

    TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces today that AdvisorShares® Investments LLC (“AdvisorShares”), a leading sponsor of actively managed exchange-traded funds (ETFs) has included Revive Therapeutics in the inaugural launch of its AdvisorShares Psychedelics ET

  • GlobeNewswire

    PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021

    TORONTO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, today released business highlights and financial results for its fiscal year ended May 31, 2021. Unless otherwise indicated, all amounts in this press release are in Canadian dollars. Fabio Chianelli, Chief Executive Officer of PharmaTher, said, “We had a tremendous year which focused on solidifying exclusive licenses for